Mitochondrial dysfunction promotes cell migration via reactive oxygen species-enhanced β5-integrin expression in human gastric cancer SC-M1 cells.
暂无分享,去创建一个
C. Chi | Hsin-Chen Lee | Kuo-Hung Huang | A. Li | P. Yin | H. Kao | Chew‐Wun Wu | Wen-Yi Hung
[1] C. Chi,et al. Somatic mutations of mitochondrial DNA in aging and cancer progression , 2010, Ageing Research Reviews.
[2] Andrei V Bakin,et al. Role of β5-integrin in epithelial-mesenchymal transition in response to TGF-β , 2010, Cell cycle.
[3] G. Pani,et al. Metastasis: cancer cell’s escape from oxidative stress , 2010, Cancer and Metastasis Reviews.
[4] Kouji Katabami,et al. Potentiation of cell invasion and matrix metalloproteinase production by α3β1 integrin-mediated adhesion of gastric carcinoma cells to laminin-5 , 2010, Clinical & Experimental Metastasis.
[5] C. Chi,et al. Somatic mutations in mitochondrial genome and their potential roles in the progression of human gastric cancer. , 2010, Biochimica et biophysica acta.
[6] Jae Hoon Jeong,et al. Mitochondrial dysfunction enhances the migration of vascular smooth muscles cells via suppression of Akt phosphorylation. , 2010, Biochimica et biophysica acta.
[7] Sen Guo,et al. Vascular endothelial growth factor (VEGF) enhances gastric carcinoma invasiveness via integrin alpha(v)beta6. , 2010, Cancer letters.
[8] A. Vercesi,et al. Mitochondria and reactive oxygen species. , 2009, Free radical biology & medicine.
[9] S. Naylor,et al. A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis. , 2009, Human molecular genetics.
[10] S. Hanks,et al. Specific cross-talk between epidermal growth factor receptor and integrin alphavbeta5 promotes carcinoma cell invasion and metastasis. , 2009, Cancer research.
[11] Yau-Huei Wei,et al. Mitochondrial DNA Instability and Metabolic Shift in Human Cancers , 2009, International journal of molecular sciences.
[12] Michael P. Murphy,et al. How mitochondria produce reactive oxygen species , 2008, The Biochemical journal.
[13] J. Hayashi,et al. ROS-Generating Mitochondrial DNA Mutations Can Regulate Tumor Cell Metastasis , 2008, Science.
[14] Michael S Janes,et al. The selective detection of mitochondrial superoxide by live cell imaging , 2008, Nature Protocols.
[15] E. Pagnotta,et al. Biochemical phenotypes associated with the mitochondrial ATP6 gene mutations at nt8993. , 2007, Biochimica et biophysica acta.
[16] Wen-Sheng Wu. The signaling mechanism of ROS in tumor progression , 2007, Cancer and Metastasis Reviews.
[17] E. Danen,et al. Integrins: Signaling, disease, and therapy , 2007, International journal of radiation biology.
[18] Marty C. Brandon,et al. Mitochondrial mutations in cancer , 2006, Oncogene.
[19] A. Chatterjee,et al. Mitochondrial DNA mutations in human cancer , 2006, Oncogene.
[20] S. Rhee,et al. H2O2, a Necessary Evil for Cell Signaling , 2006, Science.
[21] E. Bonora,et al. Defective oxidative phosphorylation in thyroid oncocytic carcinoma is associated with pathogenic mitochondrial DNA mutations affecting complexes I and III. , 2006, Cancer research.
[22] C. Chi,et al. PTPN3 and PTPN4 tyrosine phosphatase expression in human gastric adenocarcinoma. , 2006, Anticancer research.
[23] D. Wallace. A Mitochondrial Paradigm of Metabolic and Degenerative Diseases, Aging, and Cancer: A Dawn for Evolutionary Medicine , 2005, Annual review of genetics.
[24] C. Chi,et al. Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer , 2005, Genes, chromosomes & cancer.
[25] C. Chi,et al. Mitochondrial DNA mutations and mitochondrial DNA depletion in gastric cancer , 2005, Genes, chromosomes & cancer.
[26] P. Beaune,et al. Clinical value of mitochondrial mutations in colorectal cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[27] S. Ohta,et al. Positive contribution of pathogenic mutations in the mitochondrial genome to the promotion of cancer by prevention from apoptosis. , 2005, Cancer research.
[28] A. Tamori,et al. Correlation between clinical characteristics and mitochondrial D-loop DNA mutations in hepatocellular carcinoma , 2004, Journal of Gastroenterology.
[29] V. Carelli,et al. Bioenergetics of mitochondrial diseases associated with mtDNA mutations. , 2004, Biochimica et biophysica acta.
[30] G. Poli,et al. Oxidative stress and cell signalling. , 2004, Current medicinal chemistry.
[31] Marta Martínez,et al. Alteration of the bioenergetic phenotype of mitochondria is a hallmark of breast, gastric, lung and oesophageal cancer. , 2004, The Biochemical journal.
[32] Nastaran Zahir,et al. Autocrine laminin-5 ligates α6β4 integrin and activates RAC and NFκB to mediate anchorage-independent survival of mammary tumors , 2003, The Journal of cell biology.
[33] Mitsuhiro Osame,et al. Mitochondrial DNA mutation correlates with stage progression and prognosis in non‐small cell lung cancer , 2003, Human mutation.
[34] Kathy Pfeiffer,et al. Low mitochondrial respiratory chain content correlates with tumor aggressiveness in renal cell carcinoma. , 2002, Carcinogenesis.
[35] R. Seruca,et al. Microsatellite instability, mitochondrial DNA large deletions, and mitochondrial DNA mutations in gastric carcinoma , 2001, Genes, chromosomes & cancer.
[36] Arnoud Sonnenberg,et al. Function and interactions of integrins , 2001, Cell and Tissue Research.
[37] N. B. Atkin. Microsatellite instability , 2001, Cytogenetic and Genome Research.
[38] Semi Kim,et al. Regulation of Integrin αvβ3-mediated Endothelial Cell Migration and Angiogenesis by Integrin α5β1 and Protein Kinase A* , 2000, The Journal of Biological Chemistry.
[39] H. C. Lee,et al. Increase of mitochondria and mitochondrial DNA in response to oxidative stress in human cells. , 2000, The Biochemical journal.
[40] Semi Kim,et al. Regulation of Angiogenesis in Vivo by Ligation of Integrin α5β1 with the Central Cell-Binding Domain of Fibronectin , 2000 .
[41] P. Schwartzberg,et al. Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. , 1999, Molecular cell.
[42] Leslie M Shaw,et al. Activation of Phosphoinositide 3-OH Kinase by the α6β4 Integrin Promotes Carcinoma Invasion , 1997, Cell.
[43] W. Stetler-Stevenson,et al. Localization of Matrix Metalloproteinase MMP-2 to the Surface of Invasive Cells by Interaction with Integrin αvβ3 , 1996, Cell.
[44] D. Shibata,et al. Somatic mitochondrial mutation in gastric cancer. , 1995, The American journal of pathology.
[45] A. Ooi,et al. Integrin distribution in gastric carcinoma: Association of β3 and β5 integrins with tumor invasiveness , 1995 .
[46] V. Quaranta,et al. A Monoclonal Antibody Inhibits Adhesion to Fibronectin and Vitronectin of a Colon Carcinoma Cell Line and Recognizes the Integrins αvβ3, αvβ5, and αvβ6 , 1994 .
[47] C. Tzeng,et al. Cytogenetic studies of gastric adenocarcinoma. , 1991, Cancer genetics and cytogenetics.
[48] Nils Cordes,et al. Signalling via integrins: implications for cell survival and anticancer strategies. , 2007, Biochimica et biophysica acta.